Ed Cox Departs FDA, J&J Loses Opioid Lawsuit And Industry Comments On Clinical Study Reports

Citeline Podcasts - A podcast by Citeline

Try Bookbeat 60! days for free, click here

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

 Sponsored

Categories:

Business

Pink Sheet reporters discuss Ed Cox's departure from the FDA to Regeneron, Johnson & Johnson's defeat in an opioid lawsuit and industry comments on the FDA's proposal to release clinical study reports.

Visit the podcast's native language site